VANCOUVER, Washington, Mar 23, 2020 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that the […]
A leading academic medical center has administered the test medication, leronlimab, in two of their sickest COVID-19 patients. Neither patient has had any serious adverse reactions to leronlimab since it was administered. We are hopeful […]
Coronavirus Driving Demand in E-commerce and Augmented Reality NEW YORK and TORONTO, March 18, 2020 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for e-commerce and AR learning applications, has been experiencing an […]
Coronavirus Driving Demand For Work-at-home Video Conferencing Software NEW YORK and TORONTO, March 16, Mar 16, 2020 (GLOBE NEWSWIRE via COMTEX) — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for eCommerce […]
Dr. Lalezari Will Now Provide a Key Leadership Role in Accelerating CytoDyn’s Clinical Trials with Leronlimab for Coronavirus (COVID-19) and Multiple Cancer Indications VANCOUVER, Washington, Mar 13, 2020 — VANCOUVER, Washington, March 13, 2020 (GLOBE […]
NEW YORK and TORONTO, March 10, Mar 10, 2020 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for eCommerce and AR learning applications, announced that CEO Evan Gappelberg purchased 100,000 common […]
VANCOUVER, Washington, Mar 09, 2020 — Coronavirus Can Quickly Progress to Severe Pneumonia and Even Death Due to Immune Hyperactivity Including Acute Respiratory Distress Syndrome (ARDS); CytoDyn’s Trial Focuses on Patients Who Develop Mild-To-Moderate Respiratory […]
The company’s new CaptureAR App to facilitate the mass adoption of augmented reality (AR) NEW YORK and TORONTO, March 05, 2020 — NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29) NexTech, the industry leader […]
VANCOUVER, Washington, Mar 04, 2020 CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the treatment of […]
NEW YORK and TORONTO, March 03, 2020 — NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29), the industry leader in augmented reality, is pleased to announce that it has achieved revenue for the month […]
VANCOUVER, Washington, March 02, 2020 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today continued positive […]
VANCOUVER, Washington, Feb 28, 2020 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Nader […]
NEW YORK and TORONTO, Feb. 28, 2020 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for eCommerce and AR learning applications, announced that CEO Evan Gappelberg and his wife each purchased $50,000 USD […]
New customer wins expected to scale rapidly with launch of NexTech’s CaptureAR technology NEW YORK and TORONTO, Feb. 27, 2020 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for eCommerce and AR learning […]
Vancouver, CANADA– February 26, 2020 – Imagination Park Technologies Inc. (CSE: IP) (OTC: IPNFF) is pleased to announce that it has closed its previously announced convertible debenture for an oversubscribed total amount of $1,500,000. The Company intends […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
